Ensuring that safe blood and tissue products are available when they are needed is important to the health and wellbeing of Americans. The Office of Infectious Disease and HIV/AIDS Policy (OIDP) coordinates HHS activities related to blood and tissue safety and availability.
Recent Updates:
- Continued stabilization of blood collections and transfusions in the United States: Findings from the 2021 National Blood Collection and Utilization Survey
- Supplemental findings of the 2021 National Blood Collection and Utilization Survey
- Impact of the COVID-19 pandemic on blood donation and transfusions in the United States in 2020
- National Blood Collection and Utilization Survey: September 2023 Federal Register Notice for Comment
- Proceedings of the 2022 NHLBI and OASH State of the Science in Transfusion Medicine Symposium
- Executive Summary of the 2022 NHLBI and OASH State of the Science in Transfusion Medicine Symposium*
*People using assistive technology may not be able to fully access information in these files. For assistance, contact the HHS Office of Infectious Disease Policy at 202-795-7697 or by emailing acbtsa@hhs.gov.
About Blood and Tissue Safety and Availability
Find contact information for our office and learn about our history.
Roles and Responsibilities
Explore how we coordinate blood and tissue safety activities across the department.
Give Blood and Plasma
Learn about giving blood and donating plasma including what to do before, during, and after your donation; eligibility requirements; and finding a location. Also, learn about the differences in donating blood and giving plasma.
Surveys and Reports
Learn about blood, tissue, and organ initiatives.
Announcements
Find recent announcements and press releases